Abstract:In order to simultaneously perfect the release behavior and antiproliferation effect of anticarcinogen 5-fluorouracil (Fu), and achieve the dual optimization with both long-term efficacy and high-performance, thus gaining bran-new insights into the development of functional nano-formulation for anticancer pharmaceutical cocrystals, a cocrystal-entrapped micelle self-assembly strategy is proposed by integrating nanomicellar preparation and cocrystallization technologies together. Therein, the physico-chemical properties of Fu are regulated by cocrystallization technique, improving its antitumor activity; while the long-term efficacy can be maintained by giving full play to superiority of nanomicellar preparation technology. Along this line, the zwitterionic cocrystal of Fu with l-phenylalanine (Phe), viz. Fu-Phe, previously reported by our group with superior antitumor activities has been encapsulated into nanocarriers PEG-PCL, successfully assembling into cocrystal micelles, which feature the spherical particles of 182.8 nm with good uniformity and dispersion. The in vitro/vivo traits of the cocrystal micelles are systematically investigated by combining theoretical calculations with experimental tests. The outcomes suggest that the entrapment efficiency and drug loading for the obtained cocrystal micelles are far beyond Fu itself micelles, which has also been revealed by the simulation study of the interaction energy between PEG-PCL and the loaded drugs based on the theoretical calculations of electrostatic potential together with geometric optimization. The excellent encapsulation effects of the cocrystal micelles have not only given rise to ameliorated antitumor ability with low IC50 values, but eventually brought about the better in vivo pharmacokinetics with enhanced bioavailability and extended half-life. Noticeably, the present cocrystal micelles also display significant sustained-release ability relative to Fu micelles, which lays a cornerstone for further realizing the long lasting-efficacy and reducing frequent administration and even toxicity. These findings provide an innovative dosage form for Fu cocrystal with long-acting and high efficiency, thus breaking fresh pathway for the formulation development of antitumor pharmaceutical cocrystals.

Selective pharmaceutical sensitization design based on amino acid metabolism: 5-fluorouracil-sarcosine cocrystal prepared by wet powder grinding method

Chiral 5-fluorouracil-arginine cocrystals screened by wet powder grinding method: Leading to synergistic anti-tumor and alleviate cardiotoxicity

Novel insight into the mechanism underlying synergistic cytotoxicity from two components in 5-Fluorouracil-phenylalanine co-crystal based on cell metabolomics

Synthesis, Characterization, Theoretical and Experimental Anticancer Evaluation of Novel Cocrystals of 5-Fluorouracil and Schiff Bases against SW480 Colorectal Carcinoma

A novel sustained-release formulation of 5-fluorouracil-phenylalanine cocrystal self-assembled by cocrystal-entrapped micelle strategy displays enhanced antitumor efficacy

Solid state synthesis of zwitterionic cocrystal 5-fluorouracil L-phenylalanine explicated via structural, spectroscopy, quantum chemicals, Hirshfeld and docking analysis

Drug-Drug Cocrystal Alloy and Nanoformulation of Cytarabine: Optimized Biopharmaceutical Property and Synergistic Antitumor Efficacy

A novice cocrystal nanomicelle formulation of 5-fluorouracil with proline: The design, self-assembly and in vitro/vivo biopharmaceutical characteristics

5-fluorouracil-caffeic acid cocrystal delivery agent with long-term and synergistic high-performance antitumor effects

Pharmaceutical Cocrystals: A Novel Systematic Approach for the Administration of Existing Drugs in New Crystalline Form

[Synthesis, Characterization and Antitumor Activity of 5-Fluorouracil-nicotinamide Cocrystal].

The first marine dual-drug cocrystal of cytarabine with 5-fluorouracil having synergistic antitumor effects shows superior biopharmaceutical peculiarities by oral administration

Comments on "Cocrystallization of 5-fluorouracil with gallic acid: A novel 5-fluorouracil cocrystal displaying synergistic anti-tumor activity both in oral and intraperitoneal injection administration"

An Elusive Drug–Drug Cocrystal Prepared Using a Heteroseeding Strategy

The supramolecular self-assembly of 5-fluorouracil and caffeic acid through cocrystallization strategy opens up a new way for the development of synergistic antitumor pharmaceutical cocrystal

A novel drug-drug cocrystal of tegafur and myricetin: optimized properties of dissolution and tabletability

Self-assembly of antifungal agent 5-fluorocytosine and nutrient trans-p-coumaric acid furnishes a cocrystallization clue with the potential to reduce toxicity and side effects for the drug: a case research of combining theory with experiment

Bioavailability-Enhancing Cocrystals: Screening, In Vivo Predictive Dissolution, and Supersaturation Maintenance

A Drug–Drug Cocrystal Strategy to Regulate Stability and Solubility: A Case Study of Temozolomide/Caffeic Acid

Novel Pharmaceutical Cocrystals of Tegafur: Synthesis, Performance, and Theoretical Studies

Pharmaceutical Cocrystal Development of TAK-020 with Enhanced Oral Absorption